Funding Tracker/Contego Medical

Planned acquisition · Cardiovascular · United States

Contego Medical: $380M acquisition agreement

Announced November 16, 2026

The round

Contego Medical announced a Planned acquisition with approximately $380M enterprise value on November 16, 2026.

The SignalMedtronic announced its intent to acquire Contego Medical for $380 million plus potential payments. Expected closing in its fiscal third quarter is subject to customary conditions. This is an announced transaction, not a completed acquisition.

Contego Medical logo

What Contego Medical does

Integrated embolic protection and thrombectomy devices for vascular procedures.

Contego Medical develops carotid and peripheral vascular devices, including Neuroguard IEP and Excipio. Ravish Sachar, MD, and Jay Yadav, MD, founded the company. On 16 November 2026, Medtronic announced its intent to acquire Contego for $380 million plus potential payments, with closing expected in Medtronic's fiscal third quarter. Neuroguard IEP Direct received FDA PMA approval, with 510(k) clearance for its embolic protection system announced on 10 November. The company reported 0% 30-day stroke in the PERFORMANCE III intention-to-treat population and a 0.69% major adverse event rate; these are study-specific results.

Full Contego Medical profile
Enterprise value
$380M
Stage
Planned acquisition
Announced
November 16, 2026
Led by
Not disclosed
Vertical
Cardiovascular
Country
United States
Headquarters
Raleigh, NC, United States